Abstract:Background Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in the metabolism of folate. The non-synonymous single nucleotide polymorphism (nsSNP), C677T (Ala>Val, rs1801133), has been verified to impair enzyme activity. The association with cancer susceptibility, including hepatocellular carcinoma (HCC), has also been widely studied. The results, however, were inconsistent. To shed light on the influence of MTHFR C677T polymorphism on HCC, a meta-analysis was conducted. Methods The meta-analysis of C677T consisted of 10 studies (1814 cases/2862 controls). The association was measured by using random-effect (RE) or fixed-effect (FE) odds ratio (OR) combined with 95% confidence intervals (CIs) according to the studies' heterogeneity. Results Using genetic model analysis, C677T polymorphism was found to increase the risk of HCC in a complete overdominant model, which indicates that heterozygotes CT are at a lesser risk of HCC than either homozygotes CC or TT. Meta-analyses of the 10 studies showed that the TT genotype increased the risk of HCC as compared to the CT genotype: FE OR was 1.20 (95%CI: 1.00-1.45, p for heterogeneity = 0.21). When subgroup analysis was done between the HCC cases and the chronic liver disease (CLD) patients of four studies, meta-analysis showed that individuals with the TT genotype had increased HCC risk compared with those with the CT genotype: FE OR (TT vs. CT) reached 1.81 (1.22-2.71, p for heterogeneity = 0.25). Meanwhile, the C677T polymorphism also increased HCC risk in a recessive model when cases were compared to CLD patients of four studies: RE OR reached 1.85 (95%CI: 1.00-3.42, p for heterogeneity = 0.06). Overall, there was some extent heterogeneity when analyses were performed in various models. There was no publication bias. Conclusion MTHFR C677T polymorphism increased the risk of HCC in an overdominant model, and might be a risk factor for HCC occurrence, especially in CLD patients. The association warranted further studies.

Methylenetetrahydrofolate Reductase (MTHFR) Gene rs1801133 C>T Polymorphisms and Lung Cancer Susceptibility: An Updated Meta-analysis

Association Between the MTHFR A1298C Polymorphism and Risk of Cancer: Evidence from 265 Case–control Studies

Meta-analysis on the Relationship Between MTHFR Gene Polymorphisms and Colorectal Cancer

Nucleotide Excision Repair Gene ERCC1 19007T>C Polymorphism Contributes to Lung Cancer Susceptibility: A Meta-Analysis

Mthfr C677t Polymorphism And Risk Of Congenital Heart Defects: Evidence From 29 Case-Control And Tdt Studies

Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.

Meta-analysis on MTHFR polymorphism and lung cancer susceptibility in East Asian populations.

The Methylenetetrahydrofolate Reductase ( MTHFR ) C677T Polymorphism and Tumor Risk: Evidence from 134 Case–control Studies

Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk An update meta-analysis and trial sequential analysis

Influence of Methylenetetrahydrofolate Reductase C677T Polymorphism on the Risk of Lung Cancer and the Clinical Response to Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer: an Updated Meta-Analysis

Association Between Methylenetetrahydrofolate Reductase Genetic Polymorphisms and Risk of Lung Cancer

Methylenetetrahydrofolate Reductase Polymorphisms and Breast Cancer Risk: a Meta-Analysis from 41 Studies with 16,480 Cases and 22,388 Controls

Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population

Association Between the Methylenetetrahydrofolate Reductase C677T Polymorphism and Hepatocellular Carcinoma Risk: a Meta-Analysis

Association between MTHFR 677C>T polymorphism and risk of gliomas: evidence from a meta-analysis

Mthfr C677t Polymorphism Associated with Breast Cancer Susceptibility: A Meta-Analysis Involving 15,260 Cases and 20,411 Controls

MTHFR C677T polymorphism contributes to the risk for gastric cancer

Relevance of Genetic Polymorphism of Methylene Tetrahydrofolate Reductase and Susceptibility to Colonic Cancer: a Meta-analysis

Association of Polymorphisms in One-Carbon Metabolizing Genes and Lung Cancer Risk: a Case-Control Study in Chinese Population

Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility

Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility: an updated meta-analysis